5-Minute summary of the article written by Paul Sethi, Shariff K. Bishai, DO, Frank Alberta, Parth Kamdar, John Sharpe, Tim Saunders, Ellie Sheehan

5-Minute summary of the article in The Journal of Orthopaedic Experience & Innovation.

This study reviews 35 Washington State Health Care Authority HTA reports on musculoskeletal technologies, comparing coverage decisions with AAOS clinical practice guidelines. 

Orthopedic surgeons account for the most perioperative opioid prescriptions among all surgical specialties. Despite the growing emphasis on multimodal analgesia, consistent opioid-free recovery after total joint arthroplasty (TJA) has not been widely demonstrated. Suzetrigine (Journavx™), a peripherally acting sodium-channel inhibitor, represents a novel non-opioid option for postoperative pain. This study evaluated whether adding suzetrigine to a standardized, second-generation multimodal protocol was associated with high rates of opioid-free recovery after total hip arthroplasty (THA) and total knee arthroplasty (TKA).

The recording of the JOEI Zoom "Open Mic" Topic Session featuring James Ballard, MD, Michael Bolognesi, MD, and Robert Sershon, MD

The recording of the JOEI "Open Mic" Webinar featuring John Sperling, MD (moderator), Thomas Duquin, MD, David Schneider, MD, & Quin Throckmorton, MD

The recording of the JOEI Zoom "Oppen Mic" Webinar featuring Anand Murthi, MD (moderator), Nirav Amin, MD, Michael Kaplan, MD, and Jeffrey Lawrence, MD.

The recording of the JOEI Zoom "Open Mic" Webinar featuring Anand Murthi, MD, Brandon Bryant, MD, Hafiz Kassam, MD, & Michael Knudsen, MD.

The recording of the JOEI Zoom "Open Mic" Webinar featuring Matthew Abdel, MD, Jared Foran, MD, George N. Guild III, MD, & R. Michael Meneghini, MD

Featuring Herrick Siegel, MD (moderator), Richard Buch, MD, Chris Johnson, DO, Jon Minter, MD,  Jan Szatkowski, MD, MBA